| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Rapport Therapeutics, Inc.'s insiders have reduced their positions by a net 86,442 shares worth roughly $5.3M. In the past 30 days, 6 insiders bought and 2 sold. Recent activity has leaned to the buy side.
Leading the buying is PAUL STEVEN M (Director), now holding an estimated $2.1M in RAPP.
Not all activity pointed one way: 2 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), RAPP's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.28M | $251.52M | - | |
| CEO | 450.0K | $13.12M | -6,732 | |
| Other | 195.9K | $10.00M | - | |
| COO | 142.0K | $4.69M | -10,000 | |
| Other | 130.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | Sanchez Ramiro | Director | Buy | 3,600 | $27.35 | $98,477.64 | New | - | - | |
| Oct 22, 2026 | Silva Paul M | Director | Buy | 3,680 | $27.08 | $99,636.00 | New | - | - | |
| Oct 22, 2026 | Maraganore John | Director | Buy | 9,411 | $26.45 | $248,891.07 | New | - | - | |
| Oct 22, 2026 | Young Wendy B. | Director | Buy | 3,789 | $26.39 | $99,991.71 | +39.9% | - | - | |
| Oct 22, 2026 | Paul Steven M | Director | Buy | 35,714 | $27.28 | $974,277.92 | +85.7% | - | - | |
| Oct 21, 2026 | Ceesay Abraham | Chief Executive Officer | Sell | 2,210 | $29.16 | $64,447.58 | -0.5% | - | - | |
| Oct 21, 2026 | Ignelzi Troy A. | Chief Financial Officer | Buy | 5,500 | $26.10 | $143,550.00 | +55.0% | - | - | |
| Oct 7, 2026 | Ceesay Abraham | Chief Executive Officer | Sell | 4,522 | $31.68 | $143,273.00 | -1.0% | - | - | |
| Sep 30, 2026 | Gault Cheryl | Chief Operating Officer | Sell | 10,000 | $33.19 | $331,856.34 | -6.7% | - | - | |
| Sep 23, 2026 | Ceesay Abraham | Chief Executive Officer | Sell | 2,210 | $39.17 | $86,565.18 | -0.5% | - | - |